Gland Pharma has given a breakout from a bullish 'Inverted head and shoulder' pattern, and Viyash Scientific from bullish 'Cup and handle pattern', says Vinay Rajani of HDFC Securities.
Analysts said that a combination of defensive buying, strong earnings visibility, export tailwinds, and sector rotation is driving the rally in pharma stocks.
Hindalco, KEI Industries, Polycab, Apollo Hospital, Anand Rathi Wealth, GE Vernova T&D, Manappuram Finance, Navin Flurochemicals, Torrent Pharma and J B Chemicals hit fresh life-time highs on Monday.
Sentiment was further buoyed by bullish brokerage commentary, with Elara Capital and Motilal Oswal Financial Services retaining Buy calls on Gland Pharma, citing strong earnings
Among others, Sun Pharma was the top gainer up over 7 per cent, followed by Gland Pharma, Alkem Laboratories, Zydus Lifesciences and Wockhardt up over 2 per cent
The share price rose as much as 9.32 per cent to ₹1,847.10, the highest level since November 14, 2025 on the National Stock Exchange (NSE)
Gland Pharma jumped 4.80 per cent to ₹1,790.40, the highest level since December 3, 2025, on the National Stock Exchange.
Stocks to Watch today, January 8, 2026: From Tata Steel to Cipla, here is a list of stocks that will be on investors' radar